GRANT Guide

Home » Grants » 2022 SITC-Amgen Cancer Immunotherapy in Hematologic Malignancies Fellowship (worldwide)

This opportunity is currently closed.

Sign up for Content Alerts to stay informed when this or related funding opportunities are posted.

2022 SITC-Amgen Cancer Immunotherapy in Hematologic Malignancies Fellowship (worldwide)

The 2022 SITC-Amgen Cancer Immunotherapy in Hematologic Malignancies Fellowship from the Society for Immunotherapy of Cancer (SITC) with funding from Amgen, supports a postdoctoral researcher, resident, research scientist, or comparable position, working on research and translation of immunotherapeutic approaches for the treatment of patients with hematologic malignancies. Applicants must be members of SITC and hold an MD, PhD or MD/PhD degree. Applications are open to candidates worldwide. The fellowship provides funding of 100,000 USD over 1 year plus financial support to attend SITC´s 37th Annual Meeting. Applications close on April 5, 2022.

Create or sign in to your free account for more functionalities, including a full display of the eligibility criteria such as location and citizenship requirements.